Pregnancy after hydatidiform mole.
D000022:Abortion, Spontaneous; D000032:Abortion, Therapeutic; D000013:Congenital Abnormalities; D003276:Contraceptives, Oral; D003609:Dactinomycin / Q000627:therapeutic use; D036861:Delivery, Obstetric; D005260:Female; D005313:Fetal Death; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy; D007226:Infant Mortality; D007231:Infant, Newborn; D007234:Infant, Premature; D007434:Intrauterine Devices; D008727:Methotrexate / Q000627:therapeutic use; D011247:Pregnancy; D012008:Recurrence; D013997:Time Factors
D003276:Contraceptives, Oral; D003609:Dactinomycin; D008727:Methotrexate